By Ria Kakkad (Drug Target Review)2023-01-04T11:19:38
Combining AI with cutting-edge flow cytometry and massive sequencing technologies, researchers describe CAR T cell characteristics that determine their therapeutic capacity for the first time.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-26T13:58:00Z
2025-11-13T14:00:00
Sponsored by Cell Signaling Technology
2024-01-19T07:40:55
Sponsored by Euretos
2023-03-03T14:06:14
Sponsored by Bio-Techne
2023-03-08T16:29:20
Sponsored by Bio-Techne
2024-02-01T12:06:43
Sponsored by Leica Microsystems
Site powered by Webvision Cloud